A piece of news about "SEC has approved the listing of ProShares Trust $XRP ETF" spread in the market, but because the original text was worded as a general category "XRP ETF", it was mistakenly believed that this was the first approval of a US altcoin spot ETF, causing short-term emotional fluctuations in the market.A piece of news about "SEC has approved the listing of ProShares Trust $XRP ETF" spread in the market, but because the original text was worded as a general category "XRP ETF", it was mistakenly believed that this was the first approval of a US altcoin spot ETF, causing short-term emotional fluctuations in the market.

ProShares will launch three XRP futures ETFs, which were misinterpreted as spot ETFs and caused a "misunderstanding". The XRP derivatives lineup is expanding

2025/04/28 14:17
6 min read

ProShares will launch three XRP futures ETFs, which were misinterpreted as spot ETFs and caused a "misunderstanding". The XRP derivatives lineup is expanding

Author: Weilin, PANews

On the evening of April 27, a piece of news about "the U.S. Securities and Exchange Commission (SEC) has approved the ProShares Trust $XRP ETF to be publicly listed on April 30" spread rapidly in the crypto community and the market. However, because the original wording referred to the category "XRP ETF", many users mistakenly thought that this was the first U.S. altcoin spot ETF approved after BTC and ETH spot ETFs, which aroused short-term market sentiment fluctuations.

However, after verification, it was found that what ProShares was about to launch was not a spot ETF, but three futures-based XRP leveraged or inverse ETFs. Although this is an important addition to the XRP financial product system, it has not yet reached the market significance represented by the first altcoin spot ETF. This "oolong" ultimately did not have a substantial impact on the XRP price, and only triggered a small short-term increase.

Three ProShares XRP futures ETFs are coming soon

According to public information, ProShares will launch the following three new funds on April 30:

  • Ultra XRP ETF: Provides 2x leveraged XRP futures exposure
  • Short XRP ETF: Provides 1x inverse exposure to XRP futures
  • Ultra Short XRP ETF: Provides 2x inverse XRP futures exposure

The three products were initially filed in January this year, and the SEC did not raise any objections during the review, effectively acquiescing to their launch. It is worth noting that futures-based ETFs provide exposure to price fluctuations of XRP futures contracts, and these ProShares ETFs will track the price of XRP through the XRP index. This means that, unlike spot ETFs that require actual purchases of XRP tokens, futures XRP ETFs allow investors to bet on their price movements without holding XRP tokens.

Additionally, while SEC filings allow the funds to become effective on that date, actual trading may not begin immediately, depending on the readiness of the exchanges and other operational factors.

The XRP futures ETF queue has expanded, and the spot ETF is still awaiting approval.

These three ProShares funds will become the second, third, and fourth XRP-backed ETF products in the U.S. market.

Earlier this month, Vermont-based asset management company Teucrium Investment Advisors LLC launched the first XRP ETF in the U.S. market, which also provides leveraged exposure to XRP prices but does not directly hold the asset. Teucrium 2x Long Daily XRP ETF (code: XXRP) was officially launched on April 8 and aims to achieve 2 times the daily performance of XRP through swap contracts. The ETF is designed as a 2x leveraged trading tool with a daily reset mechanism.

Teucrium CEO Gilbertie said the fund is not intended for long-term holding, and warned that in a consolidating or slowly volatile market, the fund may lose value due to the compounding effect inherent in leveraged intraday reset products. Gilbertie also pointed out that the fund is mainly for aggressive traders who are bullish on XRP but cannot obtain leverage exposure through traditional margin accounts.

Regarding this product, Eric Balchunas, senior ETF analyst at Bloomberg, once wrote on the X platform: "It is very strange (and it may be the first time) that the first ETF of a new asset is leveraged. Although the spot XRP ETF has not yet been approved, we think the probability of approval is quite high."

Currently, the spot XRP ETF application submitted separately by ProShares is still awaiting approval, and similar spot fund applications submitted by asset management companies such as Grayscale, 21Shares and Bitwise are also in the same approval stage .

Leveraged ETFs have obvious short-term tool attributes

Market sentiment for ProShares' upcoming three leveraged/inverse XRP futures ETFs fluctuated only in the short term. CMC data showed that XRP was quoted at $2.177 at 8:20 p.m. on April 27 and hit a short-term high of $2.2895 at 4:05 a.m., an increase of about 5%. As of noon on April 28, the price fell slightly to around $2.25, with an overall stable trend.

Crypto KOL Tuao Dashixiong commented that "XRP leveraged/inverse ETF is a 'high-speed asset' designed for short-term trading, while BTC/ETH spot ETF is a 'slow-speed stable asset' designed for traditional investors to steadily allocate digital assets. So in fact, this ETF cannot achieve a large inflow of funds."

In addition, ProShares also clearly reminded investors in its prospectus: The prospectuses of these three ETFs clearly warned in the original text: If held for more than one day, the returns may deviate significantly from the expected returns of the underlying index, so they are not suitable for long-term holding.

It is worth mentioning that XRP's position in the derivatives market is steadily rising. Not long ago, CME Group announced that it would launch XRP futures products on its derivatives exchange on May 19. CME is the largest derivatives exchange in the United States and has currently launched products related to Bitcoin (BTC), Ethereum (ETH) and Solana (SOL).

Subsequently, Ripple CEO Brad Garlinghouse recognized CME's upcoming XRP futures contracts, saying that this is an important and exciting step for the continued growth of the XRP market. However, he pointed out that although this move has lagged behind in many aspects, it is of great significance. It marks that XRP has been recognized by the mainstream financial market. This move not only provides professional investors with regulated trading tools, but may also pave the way for the launch of XRP spot ETFs in the future, verifying XRP's status as a mature and investable asset class.

At the same time, the world's first spot XRP ETF was successfully listed in Brazil. On April 25, the world's first spot ETF linked to XRP was issued by Hashdex and managed by Genial Investimentos and began trading on the Brazilian Stock Exchange B3. The ETF code is XRPH11 and tracks the Nasdaq XRP Reference Price Index. According to Hashdex, the ETF will allocate at least 95% of its net assets to XRP.

In general, the three XRP futures ETFs launched by ProShares this time provide the market with more trading strategy options, especially for investors who focus on short-term and leveraged investments. However, from the perspective of medium- and long-term capital flows and value investment, the real focus is still on the final approval of the spot XRP ETF.

With the upcoming launch of CME XRP futures and the first listing of spot XRP ETFs in Brazil, XRP's acceptance in the global financial system has been further enhanced. In the future, if US regulators approve spot XRP ETFs, it may bring further progress.

Market Opportunity
XRP Logo
XRP Price(XRP)
$1.5788
$1.5788$1.5788
-2.42%
USD
XRP (XRP) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge

Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge

The surge follows a difficult August, when investors pulled out more than $750 million while rotating capital into Ethereum-focused funds. […] The post Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge appeared first on Coindoo.
Share
Coindoo2025/09/18 01:15
CME Group to launch options on XRP and SOL futures

CME Group to launch options on XRP and SOL futures

The post CME Group to launch options on XRP and SOL futures appeared on BitcoinEthereumNews.com. CME Group will offer options based on the derivative markets on Solana (SOL) and XRP. The new markets will open on October 13, after regulatory approval.  CME Group will expand its crypto products with options on the futures markets of Solana (SOL) and XRP. The futures market will start on October 13, after regulatory review and approval.  The options will allow the trading of MicroSol, XRP, and MicroXRP futures, with expiry dates available every business day, monthly, and quarterly. The new products will be added to the existing BTC and ETH options markets. ‘The launch of these options contracts builds on the significant growth and increasing liquidity we have seen across our suite of Solana and XRP futures,’ said Giovanni Vicioso, CME Group Global Head of Cryptocurrency Products. The options contracts will have two main sizes, tracking the futures contracts. The new market will be suitable for sophisticated institutional traders, as well as active individual traders. The addition of options markets singles out XRP and SOL as liquid enough to offer the potential to bet on a market direction.  The options on futures arrive a few months after the launch of SOL futures. Both SOL and XRP had peak volumes in August, though XRP activity has slowed down in September. XRP and SOL options to tap both institutions and active traders Crypto options are one of the indicators of market attitudes, with XRP and SOL receiving a new way to gauge sentiment. The contracts will be supported by the Cumberland team.  ‘As one of the biggest liquidity providers in the ecosystem, the Cumberland team is excited to support CME Group’s continued expansion of crypto offerings,’ said Roman Makarov, Head of Cumberland Options Trading at DRW. ‘The launch of options on Solana and XRP futures is the latest example of the…
Share
BitcoinEthereumNews2025/09/18 00:56
The FDA Is Trying To Make Corporate Free Speech Situational

The FDA Is Trying To Make Corporate Free Speech Situational

The post The FDA Is Trying To Make Corporate Free Speech Situational appeared on BitcoinEthereumNews.com. BENSENVILLE, ILLINOIS – SEPTEMBER 10: Flanked by U.S. Attorney General Pam Bondi (rear), and FDA Commissioner Marty Makary (R), Secretary of Health and Human Services Robert F. Kennedy Jr. speaks to the press outside Midwest Distribution after it was raided by federal agents on September 10, 2025 in Bensenville, Illinois. According to the company, various e-liquids were seized in the raid. (Photo by Scott Olson/Getty Images) Getty Images While running for President in 2008, Barack Obama famously chanted “Yes we can.” Love or hate his political views, Obama’s politics were quite effective. He was asking voters to think big, to envision a much better future. Advertisers no doubt approved. That’s because ads routinely evoke things not as they are, but as they could be. Gyms and exercise equipment companies don’t promote their locations and equipment with flabby, lumbering people, rather their ads show fit, upright, energetic individuals. A look ahead. Restaurants do the same with ads showing happy people enjoying impressively put together plates of food. Conversely, ads meant to convince smokers to quit have not infrequently shown the worst of the worst future downsides of the habit. The nature of advertising comes to mind as FDA commissioner Marty Makary puzzlingly brags that “The Trump Administration Is Taking On Big Pharma” in the New York Times. Makary laments pharmaceutical ads that “are filled with dancing patients, glowing smiles and catch jingles that drown out the fine print.” Not explained is whether Makary would be happier if drug companies placed ads with immobile patients, frowns, and funereal music. Seriously, what does he expect? Does he want drug companies to commit billions to drug development to accompany their achievements with imagery defined by misery? Has Makary stopped to contemplate the myriad shareholders lawsuits drugmakers would face if, upon risking staggering sums meant…
Share
BitcoinEthereumNews2025/09/18 06:29